COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Article view: 730

Article download: 206

Indian Journal of Clinical and Experimental Ophthalmology


Recurrent Meibomian gland Carcinoma of Lower Eyelid in Male: A case report


Full Text PDF Share on Facebook Share on Twitter


Author Details : Rajendra P Maurya, Virendra P. Singh, Mahendra K. Singh, P.Jain, Abihjeet Kuwanr

Volume : 1, Issue : 3, Year : 2015

Article Page : 181-183


Suggest article by email


Abstract

Meibomian gland carcinomas are very rare and locally invasive eyelid malignancies. It has predilection for upper lid and mostly occurrs in elderly females. An unique case of recurrent mebomian gland carcinoma of lower eyelid is reported in a 54 years male. Tumor and full thickness lid was excised followed by lid reconstruction by Mastarde rotational flap. Histopathology report revealed moderately differentiated meibomian gland carcinoma. One year postoperative recurrence was observed for which patient was again advised for wide surgical excision followed by post operative radiotherapy.

 
Key words: Chalazion, Eyelid reconstruction, Meibomian gland tumors, Sebaceous carcinoma

How to cite : Maurya R P, Singh V P, Singh M K, P.jain, Kuwanr A, Recurrent Meibomian gland Carcinoma of Lower Eyelid in Male: A case report. Indian J Clin Exp Ophthalmol 2015;1(3):181-183

Copyright © 2015 by author(s) and Indian J Clin Exp Ophthalmol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (creativecommons.org)